Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Teva B.V., Swensweg 5, 2031GA Haarlem, Netherlands
Hydrocortone 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, oval-shaped tablets quartersected on one side and imprinted with ‘HYD 10’ on the other side. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains 10 mg Hydrocortisone.
Excipient: Contains 191.1mg Lactose Monohydrate per tablet.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Blister packs of opaque PVC lidded with aluminium foil containing 30 tablets, presented in an outer carton.
Teva B.V., Swensweg 5, 2031GA Haarlem, Netherlands
PA1986/054/001
Date of first authorisation: 1 April 1978
Date of last renewal: 1 April 2008
| Drug | Countries | |
|---|---|---|
| HYDROCORTONE | Ireland, Lithuania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
